Kopmar, N. E., Gooley, T. A., Roloff, G. W., Zhang, A., Aldoss, I., Lin, C., … Cassaday, R. D. (2026). Real-world toxicity of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia. Blood Immunology & Cellular Therapy, 2(1), 100028–100028. https://doi.org/10.1016/j.bict.2025.100028

Kopmar, Noam E., Ted A. Gooley, Gregory W. Roloff, Amy Zhang, Ibrahim Aldoss, Chenyu Lin, Evandro Bezerra, et al. “Real-world toxicity of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia.” Blood Immunology & Cellular Therapy 2, no. 1 (March 2026): 100028–100028. https://doi.org/10.1016/j.bict.2025.100028.

Kopmar NE, Gooley TA, Roloff GW, Zhang A, Aldoss I, Lin C, et al. Real-world toxicity of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia. Blood Immunology & Cellular Therapy. 2026 Mar;2(1):100028–100028.

Kopmar, Noam E., et al. “Real-world toxicity of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia.” Blood Immunology & Cellular Therapy, vol. 2, no. 1, Elsevier BV, Mar. 2026, pp. 100028–100028. Crossref, doi:10.1016/j.bict.2025.100028.

Kopmar NE, Gooley TA, Roloff GW, Zhang A, Aldoss I, Lin C, Bezerra E, Muhsen I, Jeyakumar N, Dykes KC, O’Connor T, Tang K, Chen EC, Connor M, Frey NV, Gordillo CA, Hilal T, Al Darobi AH, Hoeg RT, Irizarry Gatell VM, Valtis YK, Jackson CW, Kota VK, Koura D, Boccucci J, Guzowski C, Kumaran MV, Ladha A, Lee CJ, Majhail NS, Malik SA, Mathews J, Miller K, Moore J, Mountjoy L, O’Dwyer KM, Odstrcil Bobillo S, Oliai CH, Oluwole OO, Pradeep R, Othman T, Ramakrishnan A, Reshef R, Sasine J, Vasu S, Schwartz M, Shaughnessy P, Stefan M, Stock W, Sutherland KC, Tan V, Solh MM, Tracy S, Luskin M, Logan AC, Leonard JT, Hill L, Tsai SB, Advani AS, Ulrickson M, Bachanova V, Dholaria B, Park JH, Battiwalla M, Faramand R, Shah BD, Yaghmour G, Muffly LS, Cassaday RD. Real-world toxicity of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia. Blood Immunology & Cellular Therapy. Elsevier BV; 2026 Mar;2(1):100028–100028.